help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 5, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2416
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
93/4/1482    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Anuurad, E.
Right arrow Articles by Berglund, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anuurad, E.
Right arrow Articles by Berglund, L.
Related Collections
Right arrow Lipid

Submitted on October 31, 2007
Accepted on January 25, 2008

High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African Americans

Erdembileg Anuurad, Jill Rubin, Alan Chiem, Russell P. Tracy, Thomas A. Pearson, and Lars Berglund*

Department of Medicine, University of California, Davis, CA, Department of Medicine, Columbia University, New York, NY, Department of Pathology, University of Vermont, Department of Community and Preventive Medicine, University of Rochester, Rochester, NY, and VA Northern California Health Care System

* To whom correspondence should be addressed. E-mail: lars.berglund{at}ucdmc.ucdavis.edu.

Background: A role of inflammation for cardiovascular disease (CVD) is established. Lipoprotein(a), Lp(a), is an independent CVD risk factor where plasma levels are determined by the apolipoprotein(a), apo(a) gene, which contains inflammatory response elements.

Design: We investigated the effect of inflammation on allele-specific apo(a) levels in African Americans and Caucasians. We determined Lp(a) levels, apo(a) sizes, allele-specific apo(a) levels, fibrinogen and CRP levels in 167 African Americans and 259 Caucasians.

Results: Lp(a) levels were increased among African Americans with higher vs. lower levels of CRP (<3 vs. ≥3 mg/L) or fibrinogen (<340 vs. ≥340 mg/dl) levels (143 vs. 108 nmol/l, P=0.009, and 146 vs. 105 nmol/l, P=0.002, respectively). We next analyzed allele-specific apo(a) levels for different apo(a) sizes. No differences in allele-specific apo(a) levels across CRP or fibrinogen groups were seen among African Americans or Caucasians for small apo(a) sizes (<22 K4). Allele-specific apo(a) levels for medium apo(a) sizes (22–30 K4) were significantly higher among African Americans, with high levels of CRP or fibrinogen compared to those with low levels (88 vs. 67 nmol/l, P=0.014 and 91 vs. 59 nmol/l, P<0.0001, respectively). No difference was found for Caucasians.

Conclusions: Increased levels of CRP or fibrinogen are associated with higher allele-specific medium-sized apo(a) levels in African Americans, but not in Caucasians. These findings indicate that pro-inflammatory conditions results in a selective increase in medium-sized apo(a) levels in African Americans, and suggest that inflammation-associated events may contribute to the inter-ethnic difference in Lp(a) levels between African Americans and Caucasians.


Key words: Inflammation • CRP • fibrinogen • allele-specific apo(a) levels • ethnicity







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society